Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-112168
Filing Date
2023-10-27
Accepted
2023-10-27 16:07:06
Documents
1
Period of Report
2023-10-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2329324-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2329324-1_4seq1.xml 4 7936
  Complete submission text file 0001104659-23-112168.txt   9394
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MERSANA THERAPEUTICS, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Bala Mohan (Reporting) CIK: 0001991787 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 231355566